ACC 2013 schedule: Difference between revisions
Jump to navigation
Jump to search
Emily Larkin (talk | contribs) No edit summary |
Emily Larkin (talk | contribs) No edit summary |
||
| Line 94: | Line 94: | ||
===2:00 PM=== | ===2:00 PM=== | ||
*'''Interviewee:''' Dr. Mikhail Kosiborod | |||
*'''Topic:''' Evaluation of Ranolazine in Patients With Type 2 Diabetes Mellitus and Chronic Stable Angina: Results From the Type 2 Diabetes Evaluation of Ranolazine in Subjects With Chronic Stable Angina (TERISA) Randomized Clinical Trial | |||
*'''Embargo lift:''' Sunday, March 10, 2013 at 11:57 AM | |||
===2:30 PM=== | ===2:30 PM=== | ||
Revision as of 20:46, 7 February 2013
Here is the page we will use to coordinate the TV events at ACC 2013. Open time slots are indicated below in red.
Filming location TBD.
Click on Date for Detailed Schedule
Friday March 8, 2013
8:00 AM
OPEN TIME SLOT
8:30 AM
OPEN TIME SLOT
9:00 AM
OPEN TIME SLOT
9:30 AM
OPEN TIME SLOT
10:00 AM
OPEN TIME SLOT
10:30 AM
OPEN TIME SLOT
11:00 AM
OPEN TIME SLOT
11:30 AM
OPEN TIME SLOT
4:30 PM
OPEN TIME SLOT
Saturday March 9, 2013
10:00 AM
10:00 AM – 10:30 AM
- Interviewee: Dr. Masahiro Natsuaki
- Topic: One-year Outcome of a Trial Comparing Second Generation Drug-eluting Stents Using Either Biodegradable Polymer or Durable Polymer: the NOBORITM Biolimus-Eluting versus XIENCETM/PROMUSTM Everolimus-eluting Stent Trial (NEXT)
- Embargo lift: Sunday, March 10, 2013 at 8:36 AM
10:30 AM
OPEN TIME SLOT
11:00 AM
11:00 AM – 11:30 AM
- Interviewee: Dr. Jean Claude Tardif
- Topic: Effects of the P-Selectin Antagonist Inclacumab in the Select-Acute Coronary Syndromes Trial
- Embargo lift: Sunday, March 10, 2013 at 11:21 AM
4:00 PM
4:00 PM – 4:30 PM
- Interviewee: Dr. Jane Margaret Armitage
- Topic: HPS2-THRIVE: Randomized Comparison Of Extended-Release (ER) niacin/laropiprant 2g Daily Versus Placebo in 25,673 Patients At High Risk Of Occlusive Vascular Events
- Embargo lift: Saturday, March 9, 2013 at 9:30 AM
4:30 PM
4:30 PM – 5:00 PM
- Interviewee: Dr. Anna Toso
- Topic: Early High-Dose Rosuvastatin for Contrast-Induced Nephropathy Prevention in Acute Coronary Syndrome
- Embargo lift: Sunday, March 10, 2013 at 8:00 AM
Sunday March 10, 2013
10:00 AM
OPEN TIME SLOT
1:00 PM
1:00 PM – 1:30 PM
- Interviewee: Dr. Margaret Redfield
- Topic: Phosphodiesterase-5 Inhibition to Improve Clinical Status and Exercise Capacity in Diastolic Heart Failure (RELAX) Trial
- Embargo lift: Monday, March 11, 2013 at 11:30 AM
1:30 PM
1:30 PM – 2:00 PM
- Interviewee: Dr. Renato Lopes
- Topic: ACC Wrap-Up in Portuguese
2:00 PM
- Interviewee: Dr. Mikhail Kosiborod
- Topic: Evaluation of Ranolazine in Patients With Type 2 Diabetes Mellitus and Chronic Stable Angina: Results From the Type 2 Diabetes Evaluation of Ranolazine in Subjects With Chronic Stable Angina (TERISA) Randomized Clinical Trial
- Embargo lift: Sunday, March 10, 2013 at 11:57 AM
2:30 PM
- Interviewee: Dr. Freek W.A. Verheugt and Dr. J.H. Cornel
- Topic: ACC Wrap-Up from a Dutch perspective
3:00 PM
OPEN TIME SLOT
3:30 PM
OPEN TIME SLOT
4:00 PM
OPEN TIME SLOT
4:30 PM
OPEN TIME SLOT